5Dahlof B, Deverexu RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpointreduction in hypertension study (LIFE): a radomised trial againt atenolol[J]. Lancet ,2002,359(9 311 ):995.
6The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major outcomes in high - risk hypertensive patients randomized to ACE inhibitor a calcium channel blocker vs diurtic--the antihypertensive and lipid lowering treatment to prevent Heart attack trial (ALLHAT)[J]JAMA, 2002, 288: 2 981.
